Led by President Jerzy Gruhn, our nine-member executive team manages our U.S. business. Each of these vastly experienced professionals leads a specific area of the business, monitoring our progress according to Novo Nordisk's Triple Bottom Line: building our business in a way that is financially profitable socially responsible and environmentally sound. The executive team has the diversity of skills, sense of purpose, and strategic vision to guide our company to consistently higher levels of success. Their combined strengths serve to cement our position as a leader in diabetes care and accelerate the growth of our biopharmaceuticals unit.
President, Novo Nordisk Inc.
Vice President, Strategic Business Operations
Vice President, Human Resources
Vice President, National Diabetes Sales
Karsten Munk Knudsen
Vice President, Finance and Information Technology
Vice President, Diabetes Marketing
Vice President, Clinical Development, Medical & Regulatory Affairs
Vice President, Biopharmaceuticals
Corporate Vice President, Global Chief Medical Officer
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy, and hormone therapy.
Stock info (NYSE quotes delayed by 15 minutes. Currency in USD)